Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1.45%
1,082.80
+15.44
+1.45%
—1,067.361,073.631,085.941,073.63——
SIXC
Communications
SIXC
Communications
SIXC
+0.05%
603.77
+0.29
+0.05%
—603.48603.48606.47601.43——
SIXE
Energy
SIXE
Energy
SIXE
-2.71%
1,211.19
-33.74
-2.71%
—1,244.931,238.101,246.591,210.94——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.48%
1,755.99
+25.61
+1.48%
—1,730.381,737.301,760.621,737.30——
SIXM
Financials
SIXM
Financials
SIXM
-0.15%
638.51
-0.96
-0.15%
—639.47639.46643.01636.91——
SIXR
Staples
SIXR
Staples
SIXR
-1.40%
842.96
-11.99
-1.40%
—854.95854.97855.66842.13——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.33%
219.28
+0.72
+0.33%
—218.56218.56220.16218.53——
SIXT
Technology
SIXT
Technology
SIXT
+2.66%
3,728.35
+96.76
+2.66%
—3,631.593,687.983,744.373,675.71——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.03%
915.48
-0.29
-0.03%
—915.77917.87921.16915.35——
SIXV
Health care
SIXV
Health care
SIXV
-1.02%
1,497.36
-15.45
-1.02%
—1,512.811,514.561,514.951,497.36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.21%
2,413.17
+4.96
+0.21%
—2,408.212,418.112,427.232,398.16——
OTLK:NASDAQ
Outlook Therapeutics Inc
$0.40
+29.14%
(+0.090) 1D
$0.40
+0.05% (+0.00020)
Pre-market
Closed: May 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OTLK...
Open
$0.46
High
$0.51
Low
$0.38
Mkt. cap
48.35M
Avg. vol.
5.20M
Volume
3.84M
52-wk high
$3.39
52-wk low
$0.16
EPS
-$1.26
Beta
0.32
Shares outstanding
120.86M
No. of employees
17
News stories
From sources across the web
About Outlook Therapeutics Inc
CEO-
Employees17
Founded2010
Headquarters-
SectorBiotechnology
Websiteoutlooktherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.51M
-91.79K
-1.21M
127.44K
Cost of goods sold
7.57M
-20.29M
29.63K
149.33K
Cost of revenue
7.57M
-20.29M
29.63K
149.33K
Research and development expenses
-
27.18M
3.63M
4.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.68M
10.33M
8.61M
9.50M
Operating expense
9.68M
37.51M
12.25M
14.01M
Total operating expenses
17.25M
17.22M
12.28M
14.15M
Operating income
-15.75M
-17.31M
-13.48M
-14.03M
Other non operating income
-2.00M
3.02M
-2.79M
6.84M
EBT including unusual items
-20.15M
-14.85M
-23.06M
-4.45M
EBT excluding unusual items
-17.83M
-14.51M
-16.31M
-7.23M
Income tax expense
-
-1.55M
-
-
Effective tax rate
-
10.47%
-
-
Other operating expenses
-
-
-
-
Net income
-20.15M
-13.29M
-23.06M
-4.45M
Net profit margin
-1,338.75%
14,482.19%
1,909.05%
-3,494.28%
Earnings per share
-0.44
-0.29
-0.22
-0.17
Interest and investment income
-
89.74K
-
3.00
Interest expense
-49.35K
-264.16K
-
-
Net interest expenses
-49.35K
-174.42K
-
3.00
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.72M
-17.28M
-13.45M
-14.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer